GSO ISO 13408-6:2023

ISO 13408-6:2021
Gulf Standard   Current Edition · Approved on 03 May 2023

Aseptic Processing of Health Care Products — Part 6: Isolator Systems

GSO ISO 13408-6:2023 Files

English 25 Pages
Current Edition Reference Language
144.45 USD

GSO ISO 13408-6:2023 Scope

This document specifies the requirements for and provides guidance on the specification, selection, qualification, bio-decontamination, validation, operation and control of isolator systems related to aseptic processing of health care products and processing of cell-based health care products.

This document does not specify requirements for restricted access barrier systems (RABS).

This document does not supersede or replace national regulatory requirements such as Good Manufacturing Practices (GMPs) and/or compendia requirements that pertain in particular to national or regional jurisdictions.

This document does not specify requirements for isolators used for sterility testing; however, some of the principles and information in this document could be applicable to this application.

This document does not define biosafety containment requirements.

Best Sellers From Health Sector

GSO 2017:2023
 
Gulf Standard
Personal Care and Baby Wet Wipes
GSO 2241:2023
 
Gulf Standard
Cosmetic Products - Body Cleaners
GSO 2063:2023
 
Gulf Standard
Cosmetic Products - Hair Conditioner (Balsam)
GSO 1223:2023
 
Gulf Standard
Cosmetic Products-Deodorants

Recently Published from Health Sector

GSO ISO 11608-7:2024
ISO 11608-7:2016 
Gulf Standard
Needle-based injection systems for medical use — Requirements and test methods — Part 7: Accessibility for persons with visual impairment
GSO ISO/TR 24666:2024
ISO/TR 24666:2023 
Gulf Standard
Sports and recreational facilities — Probes for entrapment/entanglement on playground equipment — Collection of data
GSO ISO 9713:2024
ISO 9713:2022 
Gulf Standard
Neurosurgical implants — Self-closing intracranial aneurysm clips
GSO ISO/TS 22690:2024
ISO/TS 22690:2021 
Gulf Standard
Genomics informatics — Reliability assessment criteria for high-throughput gene-expression data